| 发明名称 |
TRIMETILANGELICINA COME CORRETTORE DI CFTR IN CELLULE DELL'EPITELIO BRONCHIALE |
| 摘要 |
<p>The invention relates to the use of 4,6,4′-trimethylangelicin (TMA) and structural analogues thereof to prepare a medicament for the treatment of cystic fibrosis with the primary objective of correcting the defective CFTR in a sub-group of cystic fibrosis patients consisting of patients carrying the F508de1-CFTR mutation.</p> |
| 申请公布号 |
ITMI20111068(A1) |
申请公布日期 |
2012.12.15 |
| 申请号 |
IT2011MI01068 |
申请日期 |
2011.06.14 |
| 申请人 |
AZIENDA OSPEDALIERA UNIVERSITARIA I NTEGRATA DI VE;RARE PARTNERS SRL;UNIVERSITA' DEGLI STUDI DI BARI;UNIVERSITA' DEGLI STUDI DI FERRARA |
发明人 |
CABRINI GIULIO;CASANOVA VALERIA;GAMBARI ROBERTO |
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
